I. Whitehead

发表

The NeST (Neoadjuvant systemic therapy in breast cancer) study: National Practice Questionnaire of United Kingdom multi-disciplinary decision making

S. Irshad, C. Coles, T. Crook, 2021, BMC cancer.

The NeST (Neoadjuvant systemic therapy in breast cancer) study: National Practice Questionnaire of United Kingdom multi-disciplinary decision making

S. Irshad, C. Coles, E. Copson, 2020, BMC Cancer.

Type III interferon is a critical regulator of innate antifungal immunity

S. Kotenko, Yun-juan Chang, J. Durbin, 2017, Science Immunology.

Current practice and surgical outcomes of neoadjuvant chemotherapy for early breast cancer: UK NeST study

S. Irshad, C. Coles, E. Copson, 2022, The British journal of surgery.

Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study

Mohammad Amir Sharif, Z. Rayter, R. Bonomi, 2020, British Journal of Cancer.

The NeST (neoadjuvant systemic therapy in breast cancer) study – Protocol for a prospective multi-centre cohort study to assess the current utilization and short-term outcomes of neoadjuvant systemic therapies in breast cancer

S. Irshad, C. Coles, E. Copson, 2019, International journal of surgery protocols.

NIKHIL KAUSHAL ( NJMS 2019 ) CANCER OUTCOMES IN THE LONG-TERM PROSPECTIVE WEISS COHORT STUDIES : NEW JERSEY COHORTS

R. Birge, E. Moran, I. Whitehead, 2015 .

The NeST (Neoadjuvant Systemic Therapy in Breast Cancer) Study: National Practice Questionnaire of United Kingdom Multi-Disciplinary Decision Making

A. Shaaban, I. Whitehead, 2020 .

Bridging pre-surgical endocrine therapy for breast cancer during the COVID-19 pandemic: outcomes from the B-MaP-C study

Mohammad Amir Sharif, Amit Goyal, N. Dunne, 2023, Breast Cancer Research and Treatment.